New York, NY, US • 50 - 99 Employees
BioTech/Drugs
Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT
Alpha Particle Immunotherapeutics for CancerAcute Myeloid LeukemiaHematopoetic Stem and Cell TransplationationBiopharmaceuticalsRadioimmunotherapyHematopoeitic Stem Cell and Bone Marrow TransplantBiopharmaceuticals and ADC'sBiopharmaceuticals and ADC'sMyeloablationMultiple MyelomaBioTech/DrugsCommercial Physical ResearchBiotechnology